<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">dan</journal-id><journal-title-group><journal-title xml:lang="ru">Доклады Национальной академии наук Беларуси</journal-title><trans-title-group xml:lang="en"><trans-title>Doklady of the National Academy of Sciences of Belarus</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1561-8323</issn><issn pub-type="epub">2524-2431</issn><publisher><publisher-name>The Republican Unitary Enterprise Publishing House "Belaruskaya Navuka"</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.29235/1561-8323-2022-66-6-614-621</article-id><article-id custom-type="elpub" pub-id-type="custom">dan-1101</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МЕДИЦИНА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>MEDICINE</subject></subj-group></article-categories><title-group><article-title>Ассоциация rs699947 и rs201063 гена VEGF с уровнями фактора роста эндотелия сосудов в сыворотке крови детей с люпус нефритом</article-title><trans-title-group xml:lang="en"><trans-title>Association of VEGF gene rs699947 and rs2010963 polymorphisms with vascular endothelial growth factor levels in the blood serum of children with lupus nephritis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Никитченко</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Nikitchenko</surname><given-names>N. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Никитченко Наталья Васильевна – научный сотрудник.</p><p>ул. Академическая, 27, 220072, Минск</p></bio><bio xml:lang="en"><p>Natallia V. Nikitchenko – Researcher, Institute of Genetics and Cytology of the National Academy of Sciences of Belarus.</p><p>27, Akademicheskaya Str., 220072, Minsk</p></bio><email xlink:type="simple">N.Nikitchenko@igc.by</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Козыро</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kazyra</surname><given-names>I. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Козыро Инна Александровна – доктор медицинских наук, доцент.</p><p>пр. Дзержинского, 83, 220116, Минск</p></bio><bio xml:lang="en"><p>Ina A. Kazyra – D. Sc. (Medicine), Associate Professor, Belarusian State Medical University.</p><p>83, Dzerzhinski Ave., 220116, Minsk</p></bio><email xlink:type="simple">kozyroia@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Белькевич</surname><given-names>А. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Bialkevich</surname><given-names>H. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Белькевич Анна Геннадьевна – кандидат медицинских наук, ассистент.</p><p>пр. Дзержинского, 83, 220116, Минск</p></bio><bio xml:lang="en"><p>Hanna G. Bialkevich – Ph. D. (Medicine), Assistant, Belarusian  State  Medical  University.</p><p>83,  Dzerzhinski  Ave., 220116, Minsk</p></bio><email xlink:type="simple">belka99@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сукало</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Sukalo</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сукало Александр Васильевич – академик, доктор медицинских наук, профессор.</p><p>пр. Дзержинского, 83, 220116, Минск</p></bio><bio xml:lang="en"><p>Alexandr V. Sukalo – Academician, D. Sc. (Medicine), Professor.</p><p>83, Dzerzhinski Ave., 220116, Minsk</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гончарова</surname><given-names>Р. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Goncharova</surname><given-names>R. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гончарова Роза Иосифовна – доктор биологических наук, профессор, главный научный сотрудник.</p><p>ул. Академическая, 27, 220072, Минск</p></bio><bio xml:lang="en"><p>Roza I. Goncharova – D. Sc. (Biology), Professor, Chief Researcher, Institute of Genetics and Cytology of the National Academy of Sciences of Belarus.</p><p>27, Akademicheskaya Str., 220072, Minsk</p></bio><email xlink:type="simple">R.Goncharova@igc.by</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Институт генетики и цитологии Национальной академии наук Беларуси</institution></aff><aff xml:lang="en"><institution>Institute of Genetics and Cytology of the National Academy of Sciences of Belarus</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Белорусский государственный медицинский университет</institution></aff><aff xml:lang="en"><institution>Belarusian State Medical University</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>03</day><month>01</month><year>2023</year></pub-date><volume>66</volume><issue>6</issue><fpage>614</fpage><lpage>621</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Никитченко Н.В., Козыро И.А., Белькевич А.Г., Сукало А.В., Гончарова Р.И., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Никитченко Н.В., Козыро И.А., Белькевич А.Г., Сукало А.В., Гончарова Р.И.</copyright-holder><copyright-holder xml:lang="en">Nikitchenko N.N., Kazyra I.A., Bialkevich H.G., Sukalo A.V., Goncharova R.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://doklady.belnauka.by/jour/article/view/1101">https://doklady.belnauka.by/jour/article/view/1101</self-uri><abstract><p>Гены ростовых факторов VEGF и TGFB1 задействованы в нормальном функционировании почек, а некоторые полиморфные локусы этих генов обуславливают генетическую предрасположенность к возникновению аутоиммунных заболеваний, в том числе к системной красной волчанке (СКВ) и ее опасному осложнению – люпус нефриту (ЛН). Продукты данных генов, в частности, протеин фактора роста эндотелия сосудов и протеин трансформирующего фактора роста β1 используются в клинической практике в качестве маркеров эндотелиальной дисфункции для ранней диагностики патологии почек. Однако связь экспрессии этих протеинов с генотипами/ аллелями полиморфных локусов вышеуказанных генов изучена недостаточно. В работе был проведен анализ ассоциаций генотипов генов TGFB1 (rs1800469) и VEGF (rs699947 и rs2010963) с концентрацией их продуктов в сыворотке крови детей Беларуси с ЛН в период обострения и ремиссии заболевания. Установлена ассоциация между полиморфными  вариантами  rs699947  и  rs2010963  гена  VEGF  и  концентрацией  продукта  гена  в  сыворотке  крови у педиатрических пациентов с ЛН в период обострения. Выявлено, что гомозиготный минорный генотип AA полиморфного локуса rs699947 и группа генотипов GC + СС, содержащих не менее одного минорного аллеля локуса rs2010963, ассоциированы с более высоким уровнем продукта гена в сыворотке крови детей с ЛН в период обострения заболевания (р &lt; 0,001 и р = 0,036 соответственно). В исследовании не обнаружено достоверной связи между полиморфными вариантами гена TGFB1 (rs1800469) и содержанием его продукта в сыворотке крови. Таким образом, полиморфные варианты VEGF, ассоциированные с повышенной концентрацией продукта гена в крови при обострении заболевания, могут рассматриваться как маркеры риска обострения заболевания у пациентов с ЛН.</p></abstract><trans-abstract xml:lang="en"><p>The growth factor genes VEGF and TGFB1 are involved in the normal functioning of the kidneys, and some polymorphic loci of these genes determine a genetic predisposition to the autoimmune diseases, including systemic lupus erythematosus (SLE) and its dangerous complication, lupus nephritis (LN). The products of these genes, in particular, the vascular endothelial growth factor protein and the transforming growth factor β1 protein are used in clinical practice as markers of endothelial dysfunction for early diagnosis of kidney pathology. However, the relationship between the expression of these proteins and the genotypes/alleles of the polymorphic loci of these genes has not been studied enough, which requires clarification of this issue for the child population of Belarus. In this work, we analyzed the associations of the TGFB1 (rs1800469) and VEGF (rs699947 and rs2010963) gene genotypes with the concentration of their products in the blood serum of patients with LN during exacerbation and remission of the disease. The study did not find a significant relationship between polymorphic variants of the TGFB1 gene (rs1800469) and levels of its product in the blood. An association has been established between the rs699947 and rs2010963 polymorphic variants of the VEGF gene and the serum concentration of the gene product in pediatric patients with LN during exacerbation. It was found that the homozygous minor genotype AA of the polymorphic locus rs699947 and the group of genotypes GC + CC containing at least one minor allele of the locus rs2010963 are associated with higher levels of the gene product in the blood serum of children with LN during disease exacerbation (p &lt; 0.001 and p = 0.036, respectively). Thus, VEGF polymorphic variants associated with an increased concentration of the gene product in the blood serum during disease exacerbation can be considered as markers of the risk of disease exacerbation in patients with LN.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>системная красная волчанка</kwd><kwd>люпус нефрит</kwd><kwd>гены VEGF и TGFB1</kwd><kwd>протеин фактора роста эндотелия сосудов</kwd><kwd>протеин трансформирующего фактора роста β1</kwd><kwd>полиморфный локус</kwd></kwd-group><kwd-group xml:lang="en"><kwd>systemic lupus erythematosus</kwd><kwd>lupus nephritis</kwd><kwd>VEGF and TGFB1 genes</kwd><kwd>vascular endothelial growth factor protein</kwd><kwd>transforming growth factor β1 protein</kwd><kwd>polymorphic locus</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа выполнена в рамках задания 2.37 подпрограммы 2 «Молекулярно-генетическое изучение структурной и функциональной организации геномов растений, животных, микроорганизмов и человека как фундаментальной основы новейших геномных биотехнологий» («Структурная и функциональная геномика») ГПНИ «Биотехнологии» на 2016–2020 гг.</funding-statement><funding-statement xml:lang="en">The work was carried out within the framework of task 2.37 of Subprogram 2 “Molecular-genetic study of structural and functional organization of genomes of plants, animals, microorganisms, and humans as the fundamentals of the newest genome biotechnologies” (“Structural and functional genomics”) SPSR “Biotechnologies” for 2016–2020.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Clinical features and long-term outcomes of systemic lupus erythematosus: comparative data of childhood, adult and late-onset disease in a national register / S. Sousa [et al.] // Rheumatol. Int. – 2016. – Vol. 36, N 7. – P. 955–960. https://doi.org/10.1007/s00296-016-3450-2</mixed-citation><mixed-citation xml:lang="en">Sousa S., Goncalves M. J., Ines L. S., Eugenio G., Jesus D., Fernandes S. [et al.]. Clinical features and long-term out-comes of systemic lupus erythematosus: comparative data of childhood, adult and late-onset disease in a national register. Rheumatology International, 2016, vol. 36, no. 7, pp. 955–960. https://doi.org/10.1007/s00296-016-3450-2</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Iwamoto, T. Genetics of Human Lupus Nephritis / T. Iwamoto, T. B. Niewold // Clin. Immunol. – 2017. – Vol. 185. – P. 32–39. https://doi.org/10.1016/j.clim.2016.09.012</mixed-citation><mixed-citation xml:lang="en">Iwamoto T., Niewold T. B. Genetics of Human Lupus Nephritis. Clinical Immunology, 2017, vol. 185, pp. 32–39. https://doi.org/10.1016/j.clim.2016.09.012</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">An update on genetic susceptibility in lupus nephritis / K. Song [et al.] // Clin. Immunol. – 2020. – Vol. 215. – P. 108389. https://doi.org/10.1016/j.clim.2020.108389</mixed-citation><mixed-citation xml:lang="en">Song K., Liu L., Zhang X., Chen X. An update on genetic susceptibility in lupus nephritis. Clinical Immunology, 2020, vol. 215, pp. 108389. https://doi.org/10.1016/j.clim.2020.108389</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Biomarkers associating endothelial dysregulation in pediatric-onset systemic lupus erythematous / W. F. Lee [et al.] // Pediatr. Rheumatol. – 2019. – Vol. 17, N 1. – P. 69. https://doi.org/10.1186/s12969-019-0369-7</mixed-citation><mixed-citation xml:lang="en">Lee W. F., Wu C. Y., Yang H. Y., Lee W. I., Chen L. C., Ou L. S., Huang J. L. Biomarkers associating endothelial dysregulation in pediatric-onset systemic lupus erythematous. Pediatric Rheumatology, 2019, vol. 17, no. 1, pp. 69. https://doi.org/10.1186/s12969-019-0369-7</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Munroe, M. E. Genetics of Lupus Nephritis: Clinical Implications / M. E. Munroe, J. A. James // Seminars in Nephrology. – 2015. – Vol. 35, N 5. – P. 396–409. https://doi.org/10.1016/j.semnephrol.2015.08.002</mixed-citation><mixed-citation xml:lang="en">Munroe M. E., James J. A. Genetics of Lupus Nephritis: Clinical Implications. Seminars in Nephrology, 2015, vol. 35, no. 5, pp. 396–409. https://doi.org/10.1016/j.semnephrol.2015.08.002</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Hu, G. Revealing transforming growth factor-beta signaling transduction in human kidney by gene expression data mining / G. Hu, K. Jain, M. Hurle // OMICS. – 2005. – Vol. 9, N 3. – P. 266–280. https://doi.org/10.1089/omi.2005.9.266</mixed-citation><mixed-citation xml:lang="en">Hu G., Jain K., Hurle M. Revealing transforming growth factor-beta signaling transduction in human kidney by gene expression data mining. OMICS, 2005, vol. 9, no. 3, pp. 266–280. https://doi.org/10.1089/omi.2005.9.266</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Changes to signal peptide and the level of transforming growth factor-β1 due to T869C polymorphism of TGF β1 associated with lupus renal fibrosis / H. Susianti [et al.] // Springerplus. – 2014. – Vol. 3, N 1. – P. 514. https://doi.org/10.1186/2193-1801-3-514</mixed-citation><mixed-citation xml:lang="en">Susianti H., Handono K., Purnomo B. B., Widodo N., Gunawan A., Kalim H. Changes to signal peptide and the level of transforming growth factor-β1 due to T869C polymorphism of TGF β1 associated with lupus renal fibrosis. Springerplus, 2014, vol. 3, no. 1, pp. 514. https://doi.org/10.1186/2193-1801-3-514</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Meta-analysis of associations of vascular endothelial growth factor protein levels and –634G/C polymorphism with systemic lupus erythematosus susceptibility / W. Tang [et al.] // BMC Medical Genetics. – 2019. – Vol. 20. – P. 46. https://doi.org/10.1186/s12881-019-0783-1</mixed-citation><mixed-citation xml:lang="en">Tang W., Zhou T., Zhong Z., Zhong H. Meta-analysis of associations of vascular endothelial growth factor protein levels and –634G/C polymorphism with systemic lupus erythematosus susceptibility. BMC Medical Genetics, 2019, vol. 20, no. 1, pp. 46. https://doi.org/10.1186/s12881-019-0783-1</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative / N. Groot [et al.] // Ann. Rheum. Dis. – 2017. – Vol. 76, N 12. – P. 1965–1973. https://doi.org/10.1136/annrheumdis-2017-211898</mixed-citation><mixed-citation xml:lang="en">Groot N., de Graeff N., Marks S. D., Brogan P., Avcin T., Bader-Meunier B. [et al.]. European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative. Annals of the Rheumatic Diseases, 2017, vol. 76, no. 12, pp. 1965–1973. https://doi.org/10.1136/annrheumdis-2017-211898</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Национальный центр биотехнологической информации = National Center for Biotechnology Information NCBI, dbSNP [Электронный ресурс]. – Режим доступа: https://www.ncbi.nlm.nih.gov/snp/rs699947#frequency_tab. – Дата доступа: 10.06.2019.</mixed-citation><mixed-citation xml:lang="en">National Center for Biotechnology Information NCBI, dbSNP. Available at: https://www.ncbi.nlm.nih.gov/snp/rs699947#frequency_tab (accessed 10 June 2019).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Investigate correlated alleles for a pair of variants in high LD [Electronic resource]. – Mode of access: https://ldlink. nci.nih.gov/. – Date of access: 10.06.2019.</mixed-citation><mixed-citation xml:lang="en">Investigate correlated alleles for a pair of variants in high LD. Available at: https://ldlink.nci.nih.gov/ (accessed 10 June 2019).</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">IL-6 and TGF-β gene polymorphisms, their serum levels, as well as HLA profile, in patients with systemic lupus erythematosus / A. Paradowska-Gorycka [et al.] // Clin. Exp. Rheumatol. – 2019. – Vol. 37, N 6. – P. 963–975.</mixed-citation><mixed-citation xml:lang="en">Paradowska-Gorycka A., Roszak M., Stypinska B. [et al.]. IL-6 and TGF-β gene polymorphisms, their serum levels, as well as HLA profile, in patients with systemic lupus erythematosus. Clinical and Experimental Rheumatology, 2019, vol. 37, no. 6, pp. 963–975.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Genetic risk factors in lupus nephritis and IgA nephropathy – no support of an overlap / M. T. Vuong [et al.] // PLoS One. – 2010. – Vol. 5, N 5. – Art. e10559. https://doi.org/10.1371/journal.pone.0010559</mixed-citation><mixed-citation xml:lang="en">Vuong M. T., Gunnarsson I., Lundberg S., Svenungsson E., Wramner L., Fernström A., Syvänen A.-C., Do L. T., Jacobson S. H., Padyukov L. Genetic risk factors in lupus nephritis and IgA nephropathy – no support of an overlap. PLoS One, 2010, vol. 5, no. 5, art. e10559. https://doi.org/10.1371/journal.pone.0010559</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Single nucleotide polymorphism T869C of transforming growth factor-beta 1 gene and systemic lupus erythematosus: association with disease susceptibility and lupus nephritis / S. K. Sayed [et al.] // Egypt. J. Immunol. – 2014. – Vol. 21, N 2. – P. 9–21.</mixed-citation><mixed-citation xml:lang="en">Sayed S. K., Galal S. H., Herdan O. M., Mahran A. M. Single nucleotide polymorphism T869C of transforming growth factor-beta 1 gene and systemic lupus erythematosus: association with disease susceptibility and lupus nephritis. Egyptian Journal of Immunology, 2014, vol. 21, no. 2, pp. 9–21.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Lack of association between interleukin-10, transforming growth factor-beta gene polymorphisms and juvenile-onset systemic lupus erythematosus / A. Rezaei [et al.] // Clin. Rheumatol. – 2015. – Vol. 34, N 6. – P. 1059–1064. https://doi.org/10.1007/s10067-015-2877-2</mixed-citation><mixed-citation xml:lang="en">Rezaei A., Ziaee V., Sharabian F. T., Harsini S., Mahmoudi M., Soltani S., Sadr M., Moradinejad M. H., Aghighi Y., Rezaei N. Lack of association between interleukin-10, transforming growth factor-beta gene polymorphisms and juvenile-onset systemic lupus erythematosus. Clinical Rheumatology, 2015, vol. 34, no. 6, pp. 1059–1064. https://doi.org/10.1007/s10067-015-2877-2</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">NO-synthase inductible-2 (NOS2) and vascular endothelial growth factor (VEGF) polymorphisms in systemic lupus erythematosus among algerian patients / M. Benidir [et al.] // Lupus Science &amp; Medicine. – 2019. – Vol. 6, N 1. – Art. A87. https://doi.org/10.1136/lupus-2019-lsm.119</mixed-citation><mixed-citation xml:lang="en">Benidir M., Salah S. S., Benrebha N., Djennane M., Djoudi H., Amroun H., Tamouza R., Attal N. NO-synthase inductible-2 (NOS2) and vascular endothelial growth factor (VEGF) polymorphisms in systemic lupus erythematosus among algerian patients. Lupus Science &amp; Medicine, 2019, vol. 6, no. 1, art. A87. https://doi.org/10.1136/lupus-2019-lsm.119</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
